MiniGo vs. standard care for bowel symptoms after rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a small, portable device called MiniGo that uses a gentle water rinse to help control bowel symptoms after rectal cancer surgery. It may be an option for people who still have bothersome bowel problems despite trying other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and had surgery (low anterior resection) for rectal cancer.
- It has been 3 to 18 months since that surgery (or since a stoma reversal if you had one).
- You have bothersome bowel symptoms after surgery (like urgency, leakage, or frequent trips to the bathroom).
- You have tried other treatments for these symptoms for at least one month before this trial.
- You are physically and mentally able to use a small device (MiniGo) yourself to flush the bowel.
- You are not currently having chemotherapy, radiation, or treatment for cancer that has spread.
- You do not have inflammatory bowel disease, dementia, or a major nerve condition (like multiple sclerosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how to improve bowel symptoms in people treated for rectal cancer. It tests personalized care plans and looks at different factors that may contribute to bowel problems after surgery or a watch-and-wait approach.
This study develops an electronic diary to help track and manage bowel symptoms after rectal cancer surgery or active surveillance. It aims to create personalized care plans to improve your quality of life.
This trial tests a lower-powered stapling device for joining the bowel back together after rectal cancer surgery. It may help reduce complications while still being effective.
This trial compares two ways to help bowel control in people with low anterior resection syndrome (LARS) after low rectal surgery. It aims to see which option works better when standard treatments have not helped enough.
This trial studies a device (CG-100) placed inside the bowel to see if it can improve safety and outcomes during surgery for colorectal cancer. You would be asked to follow extra study check-ins after your operation, and the team would monitor whether the device works as intended.
This trial tests two different types of enemas (antegrade and retrograde) to help manage bowel symptoms after rectal cancer surgery and to see if they can increase the rate of ileostomy reversal. If you had a temporary ileostomy after rectal cancer surgery and are planning to have it reversed soon, this study may help improve your bowel function.
Hear when a new Gastroenterology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.